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Folate-based single cell screening using surface
enhanced Raman microimaging†
C. Fasolato,a,b S. Giantulli,c I. Silvestri,c F. Mazzarda,a Y. Toumia,d F. Ripanti,a F. Mura,e
F. Luongo,a F. Costantini,e F. Bordi,a,f P. Postorinoa and F. Domenici*a,d
Recent progress in nanotechnology and its application to biomedical settings have generated great
advantages in dealing with early cancer diagnosis. The identification of the specific properties of cancer
cells, such as the expression of particular plasma membrane molecular receptors, has become crucial in
revealing the presence and in assessing the stage of development of the disease. Here we report a single
cell screening approach based on Surface Enhanced Raman Scattering (SERS) microimaging. We fabri-
cated a SERS-labelled nanovector based on the biofunctionalization of gold nanoparticles with folic acid.
After treating the cells with the nanovector, we were able to distinguish three different cell populations
from different cell lines (cancer HeLa and PC-3, and normal HaCaT lines), suitably chosen for their
different expressions of folate binding proteins. The nanovector, indeed, binds much more efficiently on
cancer cell lines than on normal ones, resulting in a higher SERS signal measured on cancer cells. These
results pave the way for applications in single cell diagnostics and, potentially, in theranostics.
Introduction
Over the last few years, much interest in the practice of
oncology has been paid to early cancer detection, i.e. the
capability to reveal the presence of cancer at the first stage of
its progression, which could open the way to more effective
treatments.1 For this reason, a growing need has been
expressed for the development of highly sensitive and specific
detection methodologies. The current challenge is indeed to
reveal the presence of extremely few cancer cells in small,
stable biological samples, granting low invasiveness, sensing
reproducibility and high versatility with respect to the different
tumor types and metastatic spread.2,3 However, because of
tumor heterogeneity, cancer cells can often elude even specific
analyses: for this reason, the implementation of novel
detection methodologies4,5 can be crucial to address effective
diagnosis.6
In cellular diagnostics, screening consists of discriminating
cancer and normal cells either by recognizing specific cancer
cell characteristics, e.g. morphological7 or mechanical8 pro-
perties, or by selectively targeting cancer cells with traceable
markers, such as fluorescent or spectroscopically active mole-
cules.4,9 This traceability can be exploited for cell sorting, for
example in flow-cytometry assays.10,11 These methods rely on
the differential bioaffinity of the cell for specific molecules,
which can be related to a higher density of certain receptors
on cancer cell membranes.9 They have already been exploited
for diagnostics, by targeting the receptors with objects functio-
nalized with specific proteins or antibodies.12,13
Nevertheless, such macromolecules often present stability
issues, being highly sensitive to temperature, pH and other
environmental conditions, and often tend to form assemblies
with other proteins in human serum,14 inhibiting both sensi-
tivity and specificity of the biorecognition.15 Small and more
stable molecules, such as folic acid (FA), represent a promising
alternative to proteins.16 FA binding proteins are, indeed,
differently expressed depending on the cell type.17 Cancer cells
tend to express a large number of FA-receptors owing to the
pivotal role of FA in the cell metabolism and replication
process17 whereas there is a relatively low expression level in
healthy cells.16,18,19
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The folate interaction with cells is mediated by two
widely expressed facilitative transporters, solute carrier (SLC)
proteins, that are the reduced folate carrier (RFC) and the
proton-coupled folate transporter (PCFT), and via a family of
high affinity folate receptors (FRs), that transport folate via
endocytosis.20 There are three isoforms of folate receptors:
among them, FRα is highly expressed in specific malignant
tumors of epithelial origin (for example, it is strongly
expressed in cervical uterine and ovarian carcinomas, while it
is less frequent in prostate carcinoma) when compared to
normal cells.21 The basic idea is therefore to identify a suitable
technique to highlight the different densities or types of FA
receptors that can be found on different cells.
In this regard, Surface Enhanced Raman Scattering (SERS)
methodology22,23 offers a great opportunity towards a simpli-
fied, ultrasensitive detection of biomolecules involved in a
specific cellular interaction.24,25 The SERS effect is based on
the localized plasmon resonance in metallic nanostructures:
the collective excitation of electrons in a nanoparticle (Np) illu-
minated by light in the visible/infrared spectral range
increases the intensity of the electromagnetic field at the Np
surface, causing a remarkable enhancement of the Raman
signal of the molecules close to the Np.26 Gold nanocolloids
have been widely used to design biosensors for tumor
markers,25 based on their peculiar properties, such as a high
surface-to-volume ratio, which allows the possibility of suitable
biomolecular conjugation,27,28 desirable chemical stability29
and relatively low cytotoxicity.30 Exploiting their signal
enhancement capabilities, suitably functionalized Nps31,32 can
thus be used to highlight the differences among the cells in
terms of density and types of specific receptors,33 providing
the basis for cancer detection at the single cell level.34–36
Here we report a novel approach that combines the high
sensitivity of SERS with the selective recognition of FA oper-
ated by several types of cells through the different expression
of their molecular receptors.37,38 By treating the cells with a
folate-based SERS-active nanovector, our idea is to distinguish
the different cell populations based on the measurement of
the overall SERS signal intensity from a single cell. We thus
realized a SERS active nanovector, employing gold Nps,
covered with the Raman active bifunctional linker 4-amino-
thiophenol (4ATP)39–43 and further functionalized with FA.44
We performed a thorough analysis of the overall SERS
response on different treated cell types. The treatment with the
folate nanovector, under physiological conditions, was carried
out on three different cell lines known for showing different
folate receptor expressions, in terms of both density and
types.45–47 Two of them are well studied and stable tumor
models: PC-3 (prostatic cancer cells) and HeLa (cervical cancer
cells), the latter exhibiting higher expression of FRα.20,47–49 For
a comparative study we chose HaCaT immortalized keratino-
cytes, previously used as a control cell line in fluorescence-
based experiments on bioaffinity with folate.33 It is noteworthy
that these experiments were unable to detect folate nano-
carriers bound to HaCaT biorecognized receptors, possibly
because of the low density of folate binding proteins, as
recently demonstrated from the PCFT gene expression.50 On
the contrary, in the present experiment, we were able to detect
nanovectors on the HaCaT membrane, demonstrating the
higher sensitivity of SERS imaging.
A direct comparison of the SERS intensity from single cells
clearly discriminates between normal (HaCaT) and cancer
(PC-3 and HeLa) cell lines. Moreover, a statistical analysis of
the SERS signal finally proves that the present approach,
without affecting cell viability, permits one to distinguish the
PC-3 from the HeLa cancer line, owing to a more efficient
interaction of the nanovector with the latter.
Experimental
Nanovector preparation
All the preparation steps were conducted in water, ensuring a
good biocompatibility of the nanocolloidal dispersion. The
fabrication was successfully monitored at each step with
different techniques: UV-visible (UV-Vis) absorption, infrared
(IR) spectroscopy, dynamic light scattering (DLS) and Z poten-
tial and atomic force microscopy (AFM). Citrate stabilized,
gold Nps of 60 nm diameter in aqueous solution were pur-
chased from Ted Pella (Redding, CA). All the other chemicals
were purchased from Sigma-Aldrich and used without further
purification. The functionalization of Nps with 4ATP via the
S–Au bond took place in the Np aqueous solution after the
addition of a small amount of ethanol solution of 4ATP (1% in
volume at 5 mg mL−1 concentration).51 The kinetics of the
chemical reaction were followed via UV-visible absorption
measurements, which confirmed that the reaction was com-
plete after 3 hours of incubation. Residual 4ATP molecules not
bound to the Nps were removed by dialysis for 24 hours as
described by Fasolato et al.51 Afterwards, folic acid carboxylic
groups were activated with the subsequent action of 1-ethyl-3-
[dimethylaminopropyl]carbodiimidehydrochloride (EDC) and
N-hydroxy-succinimide (NHS)44,52 (see also section S1 of the
ESI†) in order to allow the covalent functionalization of the
Nps with 4ATP molecules. It is important to stress that the
4ATP-folate binding reaction does not occur with a stoichio-
metric ratio of 1 : 1, due to the stereochemical hindrance of
folic acid. Nevertheless, it is an oriented binding which
ensures the conservation of folate biofunctionality, thanks to
the molecular structure: the covalent bond involves indeed one
of the two carboxylic groups, and leaves the pteroyl active part
exposed and available for the interaction with cellular recep-
tors53 (see Fig. S1.4 in the ESI†).
UV-visible absorption measurements
The stepwise molecular assembly of FA–(4ATP–Np) has been
checked by monitoring the resonant absorption bands due to
the collective oscillations of the conductive electrons of gold
Nps, called Localized Surface Plasmons (LSPs). Absorbance
measurements were performed at room temperature (RT) by
using a double beam Jasco V-570 spectrophotometer, set with
a 0.5 nm bandwidth.
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Dynamic light scattering
The size of the Nps was characterized by means of dynamic
light scattering (DLS) measurements using a Malvern
NanoZetaSizer apparatus equipped with a 5 mW HeNe laser
(Malvern Instruments Ltd, UK). This system uses quasi-back-
scatter detection, i.e. the scattered light is collected at an angle
of 173°, the backscattering being less sensitive to multiple
scattering effects. In order to obtain the size distributions, the
measured autocorrelation functions were analyzed by using
the CONTIN algorithm. Decay times are used to determine the
distribution of the diffusion coefficients D of the particles,
which in turn are converted to a distribution of apparent
hydrodynamic radii RH using the Stokes Einstein relationship
RH = KBT/6pηD, where KBT is the thermal energy and η the
solvent viscosity. The reported radius values are the average of
several measurements and are obtained from intensity-
weighted distributions.
Z potential measurements
The Z potential of the suspended Nps was measured in water
and in the cell physiological medium at 25.0 °C temperature
(0.1 °C, T accuracy), adopting the Phase Analysis Light
Scattering (PALS) technique of a Malvern NanoZetaSizer appar-
atus (Malvern Instruments Ltd, UK). This enables the measure-
ment of the electrophoretic mobility, and from this the Z
potential, which we provided herein in the Helmholtz/
Smoluchowski approximation. The measurements were per-
formed employing a palladium electrode dip cell ZEN 1002
(Malvern, UK). The runs were set up in triplicate, each consist-
ing of at least 30 sub-runs.
Infrared absorption
The infrared characterization was performed at RT on 150 ×
150 μm2 microsized regions using a JASCO Irtron IRT-30
Fourier Transform infrared (FTIR) microscope, equipped with
a nitrogen cooled MCT detector, a Cassegrain objective 16×.
The acquisition was set up in transmission mode, 512 scans,
and at a spectral resolution of 4 cm−1. The microscope is
coupled with a FTIR/410 Jasco spectrometer equipped with a
conductive ceramic coil mounted in a water-cooled copper
jacket source and a KBr beamsplitter. The optical path was
purged continuously with gaseous nitrogen. For the microFTIR
measurements, the Np solution was dried at 37 °C on CaF2
substrates.
Raman/SERS
Raman measurements were performed employing a Horiba
HR-Evolution microspectrometer, equipped with a 25 mW He–
Ne laser (632.8 nm wavelength) and a set of neutral power
attenuating filters. The spectrometer is coupled with a con-
focal microscope equipped with a set of objectives at different
magnifications (50× – 0.50 NA and 100× – 0.8 NA were used for
this experiment). A 600 lines per mm diffraction grating
ensured a spectral resolution better than 3 cm−1. The sample
can be moved with a software-controlled mapping stage with a
sub-micrometric precision for collecting automatized spectro-
scopic mapping. Exploiting the high confocality, micrometric
sampling along the optical axes can be achieved. The data
reported in Fig. 6 were acquired by varying the focus along the
vertical axis using a 50 μm confocal hole aperture. All the
spectra are here presented after a polynomial (3rd degree) base-
line subtraction performed using LabSpec software.
Cell proliferation assay
All cell lines used in our experiments were obtained from
Interlab Cell Line Collection (ICLC) (Istituto Nazionale per la
Ricerca sul Cancro, Genoa, Italy). HaCat, a human normal
keratinocyte cell line, HeLa, a human cervical cancer cell line,
and PC-3, an androgen-independent human prostate cancer
cell line were grown in DMEM (Euroclone, Life Science
Division, GB, Pero, Italy). All media were supplemented with
100 U mL−1 penicillin, 100 µg mL−1 250 streptomycin and 10%
fetal bovine serum (Euroclone). Cells were maintained in a
tissue culture incubator at 37 °C, 5% CO2. The experiments
were performed by plating the cells at a density of 5 × 103
mL−1 in 96-well flat plates in the culture medium and then
incubated at 37 °C under 5% CO2. Following 24 hours,
different concentrations of FA–4ATP–Nps, ranging from 1 pM
to 2 pM, were added in triplicate. We performed different time
courses: a 2 hours pulse and 24 hours of treatment. The cells
were then incubated with MTT (3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium) (Sigma-Aldrich, Saint Louis,
Missouri, USA) for 4 hours. The formed crystals were dissolved
in 100 μL of DMSO and further incubated for 15 minutes. The
absorbance was measured in a plate reader spectrophotometer
(Labsystem Multiskan MS), using a test wavelength of 540 nm
and a reference wavelength of 690 nm. The cells incubated
with culture medium alone represented the controls, and wells
containing the medium alone served as blanks. All the results
were analyzed by ANOVA. The significance was evaluated by
the Tukey honestly significant difference (HSD) post hoc test
and data were expressed as means ± standard deviation (SD) of
independent samplings from different experiments. The level
of significance was established at p value <0.05.
Results and discussion
The steps of this experiment are summarized in Fig. 1. Herein,
we will firstly describe the stepwise preparation of the nanovec-
tor (A): a careful characterization was performed after each
step and at the end of the biofunctionalization. We will then
illustrate the results obtained with the treatment of the three
cell populations (B), and the monitoring of the SERS intensity
that allowed the cell recognition (C).
Nanovector preparation & characterization
The core of our nanovector consists of gold Nps of 60 nm dia-
meter, which were functionalized with a two-step process, as
described in the previous section. The results of UV-visible
spectroscopy are shown in Fig. 2(A). Note the presence of
Paper Nanoscale
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folate absorption bands and the shift of the Np plasmonic
peak, which is related to the change in the dielectric environ-
ment at the Np surface. The colloidal features of the obtained
folate nanovector were tested via both Z potential and dynamic
light scattering (DLS) measurements. As shown in Fig. 2(B),
upon conjugation with folic acid, the Np surface charge
reached a high negative value (−38 mV) which prevented the
Np aggregation through electrostatic repulsion. This was also
confirmed by DLS measurements, which provided a size distri-
bution centred around 70 nm diameter (Fig. 2(C)), in agree-
ment with the estimate obtained by SEM imaging (see Fig. 2(D)).
Similar results imply the stability of the nanovector also in cell
culture medium (see section S2.1 of the ESI†).
The spectroscopic characterization was completed with
Fourier transform infrared absorption measurements. The
extra peak in the spectrum of the complete nanovector (Fig. 3(C)),
when compared to the spectrum of 4ATP functionalized
Nps (Fig. 3(B)), can be related to the presence of the folate
shell bound to the Nps (Fig. 3(A)). Indeed, the IR absorption
band centered around 1700 cm−1 is assigned to the carbonyl
group (–CONH– in the case of FA–4ATP–Np complex).54 Slight
intensity modification and frequency shifts in the nanovector
spectrum with respect to the bulk are ascribed to the gold Np
surface enhanced infrared absorption effect.55 Titration experi-
ments using the Coomassie Brilliant Blue (CBB) dye allowed
for a quantitative estimation of the number of folate molecules
bound to the single Np.56 The result shows an average number
of 1900 ± 200 folate molecules (see section S3 of the ESI†).
This is in good agreement with the approximated, theoretical
estimate (∼2000 molecules) formulated by considering folate
stereochemical hindrance (around 2000 molecules).
SERS features of the nanovector
The typical SERS spectrum of the nanovector is shown in
Fig. 4(A): the spectroscopic fingerprint is highly reproducible
and can be mainly ascribed to the Raman reporter 4ATP.57,58
This can be due to several reasons, among which the higher
distance of folate molecules from the Np surface, the low
Fig. 1 Sketch of the experiment, which consists of: (A) bioconjugation
of SERS-active gold nanoparticles with 4ATP and then with folic acid;
(B) treatment of three cellular populations, with different levels of
folate receptor expressions (HaCaT “normal” cells, PC-3 “cancer 1” cells,
HeLa “cancer 2” cells) and selective cellular binding of the nanovector;
(C) SERS measurements on the cells, which allowed the discrimination
of the cell populations based on the different density of folate receptors
and carriers on the membrane.
Fig. 2 Nanovector characterization during the functionalization. Panel
(A): UV-visible absorption measurements on bulk folic acid (dashed-
dotted line) and complete nanovector (solid red line). Inset: shift in the
plasmonic peak of gold Nps at different functionalization steps: bare Np
(black), 4ATP–Np (blue) and FA–4ATP–Np (red). Spectra are normalized
to the plasmonic peak intensity. Panel (B): Z potential measurements at
different intermediate functionalization steps. Panel (C): dynamic light
scattering size measurement of bare Np (black) compared to FA–4ATP–
Np (red). The final size distribution is centered around 70 nm, as
revealed also by FESEM measurements shown in panel (D). The latter
image was acquired from a Np deposition on a glass slide, at low voltage
(1 kV) to avoid sample degradation and without metallization.
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Raman cross section of folic acid (see Fig. S2 in the ESI†), and
the fact that, according to our estimate, the covalent attach-
ment between FA and 4ATP onto the Np surface occurred with
a stoichiometric ratio of around 1 : 6 (section S3 of the ESI†).
Nevertheless, weak but clear and reproducible modifications
of the 4ATP SERS spectrum upon functionalization witness the
occurrence of folic acid binding. Indeed, according to the
literature, a few cm−1 frequency shift and/or a slight change in
the line-shape of some peaks can be reliable in witnessing
chemical conjugation in the case of 4ATP.59,60 In particular,
the phenyl ring C–C stretching Raman band results in a strong
intense SERS signal observed around 1580 cm−1 and suscep-
tible to be influenced by the type of chemical substituent and
its electronic properties.41,42,61–63 Considering this, we per-
formed a comparative high-resolution spectral analysis on this
band with respect to folate biofunctionalization. The average
spectra corresponding to 4ATP–Np and FA–4ATP–Np are sum-
marized in Fig. 4(B). There is a strong change in the relative
weight of the two components of the band, whose central fre-
quencies are highlighted in the spectrum of Fig. 4(B), in favor
of the low frequency component for the biofunctionalized
sample (see section S4.2 of the ESI† for details), the latter
suggesting that some of the NH2 substituents of 4ATP were
actually modified according to section S1 of the ESI.†
Overall, the characterization outcome (by UV-Vis, Z poten-
tial, IR, CBB titration assay) coherently points out the presence
of folate in the functionalized Np sample, even after a long
dialysis, suggesting a tight binding between folate and 4ATP.
This is well evidenced also by SERS spectra: a change in the
band shape of the phenyl ring C–C vibration can be ascribed
to a significant change in the charge delocalization of the aro-
matic ring of 4ATP due to the occurrence of a typical meso-
meric effect63,64 (see section S4.2 and Fig. S4.4 of the ESI† for
a more detailed discussion). Note that different biofunctionali-
zation procedures (e.g. diazotization reaction28) were here
avoided, with the folate derivatization involved in its pteroyl
active part.53
Cell treatment and SERS investigation
The cell treatment consisted of incubating the nanovector
aqueous solution in the live cell culture for 2 hours. Nps
unbound to the cell receptors were washed away with PBS after
incubation. MTT viability tests confirmed the negligible cyto-
toxicity induced by the nanovector, which was detected for
24 hours of incubation (see section S7 in the ESI†).
According to the Experimental section, the cellular samples
were stabilized for Raman/SERS measurements by drying them
under a laminar flow at a controlled temperature of 37 °C,
without any further chemical fixing treatment. All cell lines,
treated and not treated, were measured with Raman spec-
troscopy. Some representative spectra obtained on the PC-3
cancer cells and on the HaCaT normal cells in the region
between 1000 and 1700 cm−1 are shown in Fig. 5 (see section
S3 in the ESI† for assignment). The spectrum of an untreated
cell is then compared with the spectra collected on the PC-3
treated cells (low and high SERS intensity) and on the HaCaT
normal cells. The reference spectrum of the nanovector is also
presented. It is straightforward to ascribe the strong bands
revealed on treated cells, and in particular the ones evidenced
in light blue, to the presence of the nanovector. In the case of
low SERS signals, it is still possible to distinguish the cell
signal, not masked by SERS peaks (see the grey region).
These spectral features thus allow one to clearly identify the
signal arising from the nanovector in the spectrum collected
Fig. 3 FTIR measurements on bulk folic acid (A), 4ATP–Nps (B) and
FA–4ATP–Nps (C). The yellow region highlights the carbonyl group
band of folic acid.
Fig. 4 Panel (A): SERS spectra from 4ATP–AuNps (blue), and from
FA–4ATP–AuNps (red). Panel (B): SERS spectrum around the C–C
stretching band at about 1580 cm−1. Notice the frequency shift and the
peak line-shape modification, occurring upon functionalization.
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from each cell. As a first qualitative comparison, we noticed
that the nanovector signal arising from acquisitions performed
on the PC-3 and HeLa cells is much bigger than that measured
on HaCaT, the latter cells expressing PCFT only.50 This finding
confirms the original idea about the possibility of developing a
spectroscopic procedure to discriminate cancer and normal
cells, based on their different FA receptor expression levels.
Before discussing in detail the SERS-based protocol we develo-
ped for single cell screening (see the next subsection), we want
to stress that these spectroscopic measurements allow for a
detailed investigation of the nanovector–cell interaction. In
particular, Raman imaging allowed us to understand where
and how the nanoparticles bind to the cells. Indeed, by exploit-
ing the high confocality of our microspectrometer we were
able to optimize the spatial resolution along the optical axes to
a few microns, collecting the signal from a very thin focus
region. Combining SERS with the micrometric resolution
either along the vertical axes or over the sample surface allows
investigating the distribution of the Nps all over the cell
surface. The representative results for a PC-3 cell are shown in
Fig. 6. The very good correspondence between the optical
image and the cell Raman map (integrated intensity of the
lipid CH2–CH3 stretching peaks vs. horizontal position) in
Fig. 6(D) makes us confident to fully exploit spectroscopic
imaging. SERS intensity maps (integrated intensity of a nano-
vector specific peak vs. horizontal position) shown in Fig. 6(A)
are compared with optical images (Fig. 6(B)). Maps and relative
images are collected moving the focus plane of a few microns
along the optical axes as shown by the schematic in panel (C),
where a detailed stratigraphic analysis of the cell is also
shown. The integrated intensities (normalized) of the nanovec-
tor-, cell- and substrate-specific peaks vs. vertical position z are
shown in the graphic in Fig. 6(C). The maximum of these
three signals is found at different vertical positions, being that
of the nanovector located ∼1 μm above that of the cell, which
in turn is located ∼2 μm above that of the substrate. This verti-
cal arrangement suggests that the nanovector is located out of
the cell but close to the membrane. This picture is in agree-
ment with FESEM imaging (see Fig. S5.4 and experimental
details in the ESI†) showing that the great majority of the Nps
are clearly visible outside the cell membrane, while only a few
of them are apparently located inside the cell.
It is also worth noting that illuminating the Nps with the
red beam (633 nm) leads to the sensitivity to the Np density,
as the SERS signal coming from “hot-spots” resulting from Np
aggregation is considerably more intense than the one coming
from a single, isolated Np, because of the changes in the
shape of the surface plasmon peak arising from Np aggrega-
tion.29 The fact that aggregation takes place in the presence of
a dense receptor distribution was confirmed by scanning elec-
tron microscopy imaging, which allowed us to monitor the
successful binding of Np to the cell membrane (see section S5
in the ESI†).
SERS screening & diagnostics
In this section the protocol developed for the SERS bio-
recognition of single cells is described. Once focused on a cell
Fig. 5 The typical Raman spectrum (solid-black) of PC-3 cancer cells is
compared with the spectra of treated PC-3 cells: dotted-red and solid-
red lines refer to low and high SERS intensities. The spectrum of a
normal HaCaT treated cell (solid-purple) and the one of the nanovector
(solid-blue) are shown for comparison. The peaks centered at 1078 cm−1
and 1580 cm−1 (see the blue-shaded areas) are the SERS markers of the
nanovector bound to the cell membrane.
Fig. 6 (A) SERS imaging obtained by integrating the C–S stretching
peak of 4ATP and plotted in the thermal scale is correlated with the
optical image of the cell (B). The measurements were performed varying
the focus of the objective at different values of z. Nps seem to be
located at the margins of the cell, as pointed out by Boca-Farcau et al.37
(C) Intensity of SERS and Raman peaks relative to the different com-
ponents of the system acquired varying the objective focus (versus z).
(D) The imaging of the cell performed integrating the lipid membrane
CH2–CH3 stretching peaks shows a good correspondence with the
optical image, giving information on the location of the cell nucleus
(double membrane and higher signal).
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treated with the SERS active folate nanovector, we carried out a
fast, automatized spectroscopic sampling of the cell mem-
brane by collecting 9 spectra all over the cell area (see Fig. 7(A)).
In order to obtain a single, simple control parameter from
each cell, the integrated intensity of the nanovector-specific
SERS band (centred at 1580 cm−1), ISERS, was calculated for all
the spectra and its value was normalized to the substrate inte-
grated intensity, Isubstrate, to account for slightly different
experimental conditions from cell to cell. Further details of
this procedure are given in section S6 of the ESI.† Values
obtained for the control parameter, actually defined by C =
1000 × ISERS/Isubstrate, confirmed the qualitative finding men-
tioned above, that is the selective targeting of the different cell
populations induced by folate specific biorecognition. The
average control parameter value indeed systematically
increases going from HaCaT (non-cancer, 〈C〉 = 5) to PC-3
(cancer, 〈C〉 = 75) to HeLa (cancer, with the highest over-
expression of FA receptors, 〈C〉 = 196).
A blocking experiment was also performed, to be sure that
the above results are really induced by folate specific bio-
recognition. To this aim, HeLa cells were incubated with the
nanovector, in the presence of a high concentration of
unbound folate molecules in solution. After performing the
usual protocol (see Experimental for details), a population of
100 cells from the ordinarily treated sample was screened and
compared with a 100-cell population of the blocking experi-
ment sample. The obtained results are compared in the box
plot shown in Fig. 7(B). As it is shown, there is a neat decrease
of the signal on folate-blocked cells, indicating a competition
between the free folate molecules and folate functionalized
nanoparticles for the molecular binding sites on the cell mem-
brane, resulting in a lower density of Nps on blocked cells, and
therefore in a lower intensity of the overall SERS signal.
The results of SERS screening obtained for three 100-cell
populations of HeLa, PC-3 and HaCaT cells are reported in a
histogram in Fig. 7(C). The occurrence frequencies of different
intervals of the parameter C are evident. The logarithmic
binning was chosen because of the wide range of C values
measured. The data for the three cell populations follow the
same statistical behaviour, which we chose to model as a log-
normal distribution,65 but with largely different parameters.
The optimal fitting lognormal curves are plotted in a solid line
over the histograms. Differences can be noticed among the
three populations: in the case of the HaCaT line, a distribution
peaked around small values of C reflects the very low density
of FA binding proteins on the surface of normal cells.
Moreover, the two populations of cancer cells can be distin-
guished, with the expected value of the PC-3 control parameter
being quite lower than the one in the case of HeLa cells.
A semi-quantitative interpretation of the data in terms of
the density and the type of folate binding proteins on the cell
membrane is possible.65 Indeed, biological investigation on
the HeLa cell line showed an undiscussed overexpression of
FRα, in addition to a higher density on the membrane of the
folate solute carriers, as RFC and PCFT.47,48 The case of PC-3
is more controversial, as there are different hypotheses on the
expression of folate binding proteins on these cells.18,46,47,66
Most probably, the overexpression of the folate solute carriers
Fig. 7 (A) Sketch of the screening measurement protocol performed on measured cells (see the text for details). (B) Boxplot showing SERS signals
measured on screened HeLa treated cells (right, dark green box) and HeLa cells on which a blocking experiment was performed (left, light green
box) by adding free folate to compete with the nanovector in reaching the cell receptors. See the text for a detailed explanation. (C) Histogram
showing the occurrence of different values of the control parameter (see the text). The logarithmic binning was chosen because of the wide range
of the C parameter measured on the different cell populations.
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is the one responsible for the enhanced targeting of the PC-3
cells with respect to the HaCaT population.50 The clearly
higher signal on the HeLa cells is in good agreement with the
idea of the overexpression of the folate receptor FRα, in
addition to the solute carrier overexpression on the PC-3 cells.
The statistical interpretation of our data, although it may be
improved, paves the way for the implementation of hypothesis
testing for new data.
Conclusions
In recent years, the need to develop methodologies for early
cancer detection has significantly grown. In this context, the
sensitivity and the timing of diagnosis need to be improved in
order to lead towards a more effective treatment. In this frame-
work, several folic acid mediated cell targeting strategies have
been recently proposed.67 Indeed, the degree of over- and
hypo-expression of folate binding proteins on the cell mem-
brane enables the discrimination between normal and cancer
cells and, among the latter, it could provide insight into the
different stages of the disease (as in the case of metastatic
tumors), when those transformations and progress imply a
change in the expression level of folate receptors and car-
riers.68 Nevertheless, these methods, which rely on cellular
selective recognition, suffer the absence of analysis method-
ologies with suitable sensitivity and reproducibility.
Surface enhanced Raman microspectroscopy has proved its
potentiality in biosensing applications, although the high sen-
sitivity and selectivity of this technique come together with
non-negligible reproducibility issues, which have been widely
reported.57,69 Despite the advantages in using SERS for bio-
physical investigations, to the best of our knowledge, SERS
based screening of multiple and different cell lines, based on
the receptor expression, has not yet been reported.38 For this
reason, we focused on the differential expression of membrane
folate binding proteins of different cell lines, in order to
develop a SERS-biorecognition strategy leading to single cell
screening.
To this aim, we assembled a simple SERS active bio-nano-
particle platform where folic acid was interfaced to the plasmo-
nic gold Np coated with the Raman reporter 4ATP. As shown in
Fig. 2 and 3, the functionalization of the nanovector was suc-
cessfully performed in water, ensuring a good biocompatibility
of the system, and proved with different experimental tech-
niques. The stability of the nanovector in cell culture medium,
resulting from the negative surface charge given by the car-
boxylic groups (Fig. S1.4 in the ESI†) and witnessed by the size
distribution measurements (see Fig. S2.2 in the ESI†), prevents
the formation of an adhesion layer of proteins around
the nanovector, which could impact on the selectivity, as
happens in some cases with protein-based functionaliza-
tions.15 The titration experiments allowed one to ascertain that
the 4ATP–Nps can be biofunctionalized efficiently with an
average number of ∼1900 molecules of FA (see section S3 of
the ESI†). The SERS activity of the system was proved with a
thorough investigation of the features of the SERS spectrum
of the Np–4ATP–folate adduct, as compared to the well-known
Np–4TP system,51 and further confirmed the functionalization
that occurred.
The experiment of cell biorecognition was performed with
the incubation of three different cell lines, chosen for their
different levels of expression of folate receptors.20,21 The selective
binding of the nanoparticles to the molecular receptors is
favoured by the orientation of folic acid molecules on the Np
surface, which exposes the heterocyclic part of the molecule
for the interaction with the cell.53 This selectivity was also
proved with a blocking experiment (see the subsection SERS
screening & diagnostics). The design of a screening procedure,
based on the SERS spectroscopic imaging of the cells,
allowed for monitoring the overall SERS response, at the single
cell level, on 100-cell populations. With proper statistical
analysis, we were able to distinguish the typical SERS signals
belonging to human cell models of the non-tumorigenic kera-
tinocyte HaCat line, metastatic prostate cancer PC-3 line, and
uterine cervical cancer HeLa line. The detectable, low signal
measured on the HaCaT cells proves the sensitivity of our
method, and the capability to detect the presence, on HaCaT
membranes, of the few folate solute PCFT carriers expressed,
which are necessary for the cellular folate supply.50 The differ-
ence between the response of the HeLa and PC-3 cells is
ascribed mainly to the presence of the FRα receptor, which is
known to be present in a comparatively higher density on the
HeLa membrane.20,21,47
Among the advantages of our method, we must recall the
rather rapid time of incubation with the nanovector, when
compared to similar studies:49 for this reason, we can state
that there is no change in the cell population during the treat-
ment. Treatment can be realized under physiological con-
ditions (cell culture medium, 37 °C temperature), without
preventing the selective binding of the nanoparticle to the
folate receptors. Cytotoxicity measurement ensured that,
during the treatment, the viability of the cell culture remains
unvaried by the presence of the nanovector, granting the
reliability of the procedure (see section S7 of the ESI†). We
stabilized the cellular sample only by drying it, without further
addition of fixing agents, which could affect the spectroscopic
response of the system.
It has to be emphasized that the characteristics of this
nanovector make it suitable as a membrane receptor label for
studies of near field microscopy, scanning probe and elec-
tronic microscopy techniques (see for example section S5 in
the ESI†). According to our estimate on the HeLa cell line, the
treatment gave rise to approximately 100 Np-receptor binding
events per cell. This is in good agreement with the Np density
that can be inferred from SEM measurements (see section S5
of the ESI†), and with the expected high (approximately nM)
folate-receptor affinity. The use of a red laser for SERS exci-
tation, while avoiding the damage of the sample and therefore
ensuring a high reproducibility of the analysis, with sensitivity
to the presence of nanoparticle aggregates rather than single
nanostructures.29 This means in turn that the SERS screening
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shown in Fig. 7 is related to the spatial distribution of the
folate receptor density rather than to the presence of single
receptors. On one hand, this reduces the risk of single, non-
specific binding events affecting the measurement; on the
other hand, this prevents to detect the presence of many
single, isolated Nps (see Fig. S5.4 and S5.5 in the ESI†). In
order to further enhance the diagnostic sensitivity, it could be
useful to induce the nanovector ad hoc aggregation (e.g. in
dimers) before treating the cells.
The overall results prove the possibility of reaching statisti-
cally relevant responses starting from rather small cell popu-
lations, if compared with the statistics required for example by
fluorescence-based methods. Although we have not yet realized
in vivo studies, the small size, the stability and the negligible
cytotoxicity of the nanovector make our method a good candi-
date for such investigations, also in view of possible theranos-
tic applications.
Given the positive correlation between the FRα expression
and tumor stage and grade, the role of FA in tumor pro-
gression was indeed evidenced.21 In this respect, folate
binding competitors (also known as antifolate drugs, e.g.,
aminopterin and methotrexate), have been developed over
several decades for the treatment of cancer and inflammatory
diseases.18,19,53,70 To date, antifolates approved for clinical
use enter cells via RFC (primarily) and PCFT solute carriers,
and by folate receptors.19,48 As an overexpression of FRα
seems a typical characteristic of cancer cells, a predominant
internalization of antifolate loaded nanovectors via FRα
would be desirable in order to improve the treatment speci-
ficity, while limiting collateral damage on normal cells. For
this reason we are currently testing the same Np functionali-
zation protocol substituting/including folate and antifolate
drug aminopterin (AMT). From our tests is emerging an
intriguing significant increase in HeLa cell mortality after
incubation with the AMT-nanovector, suggesting a valuable
role of SERS folate-Nps to design valuable traceable multi-
therapeutics carriers.
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